TAF only superior to TDF when used with a boosting agent
Twice-daily dolutegravir is safe and effective when used alongside TB treatment
New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose
Experts concur that event-related oral PrEP probably won’t work for women
Trans women wary of antiretroviral drug and hormone interactions
Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals
The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study
Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels
